Anti-Human MAP1LC3C Antibody
Anti-Human MAP1LC3C Antibody with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
MAP1LC3C is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthetic peptide of human MAP1LC3C; purification: Affinity purification; concentration: 0.8 mg/mL.
Database references: UniProt: Q9BXW4 | NCBI Gene: 440738.
Research Use Only.
Key Facts
| Target | MAP1LC3C |
| Also known as | ATG8J, Autophagy-related protein LC3 C, Autophagy-related ubiquitin-like modifier LC3 C, LC3 like protein 2, MA, MAP1 light chain 3 like protein 2, MAP1 light chain 3 like protein 3, MAP1 light chain 3-like protein 3, MAP1A/MAP1B LC3 C, MAP1A/MAP1B light chain 3 C |
| Concentration | 0.8 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Cardiovascular, Metabolism, Signal Transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.